Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages

被引：12
作者：
Fitzgerald-Hughes, Deirdre [1 ]
Bolkvadze, Darajen [2 ]
Balarjishvili, Nana [2 ]
Leshkasheli, Lika [2 ]
Ryan, Maia [2 ]
Burke, Liam [1 ]
Stevens, Niall [1 ]
Humphreys, Hilary [1 ,3 ]
Kutateladze, Mzia [2 ]
机构：
[1] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Clin Microbiol, Dublin 9, Ireland
[2] G Eliava Inst Bacteriophages Microbiol & Virol, Lab Mol Biol, Tbilisi, Georgia
[3] Beaumont Hosp, Dept Microbiol, Dublin 9, Ireland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2014年 / 69卷 / 04期
关键词：
Enterobacteriaceae; Ses phages; Enko phages; bacteriophage lysis; phylogenetic groups;
D O I：
10.1093/jac/dkt453
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1148 / 1150
页数：3
相关论文
共 10 条
  • [1] ADAMS M, 1961, BACTERIOPHAGES
  • [2] Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy
    Bruttin, A
    Brüssow, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2874 - 2878
  • [3] The revolving door between hospital and community: extended-spectrum beta-lactamase-producing Escherichia coli in Dublin
    Burke, L.
    Humphreys, H.
    Fitzgerald-Hughes, D.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2012, 81 (03) : 192 - 198
  • [4] Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]
  • [5] EUCAST, 2013, BREAKP TABL INT MICS
  • [6] Phage Therapy in Clinical Practice: Treatment of Human Infections
    Kutter, Elizabeth
    De Vos, Daniel
    Gvasalia, Guram
    Alavidze, Zemphira
    Gogokhia, Lasha
    Kuhl, Sarah
    Abedon, Stephen T.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (01) : 69 - 86
  • [7] Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
    Merabishvili, Maya
    Pirnay, Jean-Paul
    Verbeken, Gilbert
    Chanishvili, Nina
    Tediashvili, Marina
    Lashkhi, Nino
    Glonti, Thea
    Krylov, Victor
    Mast, Jan
    Van Parys, Luc
    Lavigne, Rob
    Volckaert, Guido
    Mattheus, Wesley
    Verween, Gunther
    De Corte, Peter
    Rose, Thomas
    Jennes, Serge
    Zizi, Martin
    De Vos, Daniel
    Vaneechoutte, Mario
    [J]. PLOS ONE, 2009, 4 (03):
  • [8] Rhoads D D, 2009, J Wound Care, V18, P237
  • [9] Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
    Woodford, Neil
    Turton, Jane F.
    Livermore, David M.
    [J]. FEMS MICROBIOLOGY REVIEWS, 2011, 35 (05) : 736 - 755
  • [10] A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
    Wright, A.
    Hawkins, C. H.
    Anggard, E. E.
    Harper, D. R.
    [J]. CLINICAL OTOLARYNGOLOGY, 2009, 34 (04) : 349 - 357
1